Login
$CLB
$8.67 -$0.44 (4.83%) Live

$CLB SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G/A
30 Oct 2026 10-Q
28 Oct 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

HOUSTON (October 28, 2026)—Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported third quarter 2026 revenue of $132,100,000. Core’s operating income was $12,100,000, with earnings per diluted share (“EPS”) ...

05 Oct 2026 Form 4: Tattoli Mark Damian, SVP, Gen Counsel & Secretary

Gave up 276 shares to cover exercise price or tax ($2.69K) · Received 700 shares by exercise or conversion

05 Oct 2026 Form 4: Teo Sow Hang, CAO & Treasurer

Gave up 99 shares to cover exercise price or tax ($966) · Received 250 shares by exercise or conversion

25 Aug 2026 8-K: Departure/Election of Directors or Officers; Compensation

I write to inform you of my decision to resign from my position as a member of the Board of Directors of Core Laboratories, where I am the chairman of the Nominating, Governance, and Sustainability Committee, and member of the Compensati...

14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
06 Aug 2026 SCHEDULE 13G/A
04 Aug 2026 Form 4: Bruno Lawrence, Director

Bought 5,000 shares ($53.9K)

04 Aug 2026 Form 4: Teo Sow Hang, CAO & Treasurer

Gave up 198 shares to cover exercise price or tax ($2.11K) · Received 440 shares by exercise or conversion

04 Aug 2026 Form 4: Tattoli Mark Damian, SVP, Gen Counsel & Secretary

Gave up 99 shares to cover exercise price or tax ($1.05K) · Received 250 shares by exercise or conversion

30 Jul 2026 10-Q
29 Jul 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

HOUSTON (July 29, 2026)—Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported second quarter 2026 revenue of $124,600,000. Core’s operating income was $9,200,000, with earnings per diluted share (“EPS”) of ...

29 Jun 2026 11-K
15 May 2026 SCHEDULE 13G/A
15 May 2026 SD
13 May 2026 8-K: Submission of Matters to a Vote of Security Holders

Core Laboratories Inc. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”) on May 12, 2026 in Houston, Texas. At the Annual Meeting, the Company’s shareholders were asked to vote on the following proposals: (1)...

04 May 2026 Form 4: Tattoli Mark Damian, SVP, Gen Counsel & Secretary

Gave up 97 shares to cover exercise price or tax ($1.36K) · Received 250 shares by exercise or conversion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support